Free Subscription

  • Access 15 free news articles each month

Professional

Try one month for $7
  • Unlimited access to news,insights and opinions
  • Quarterly and weekly magazines
  • Independent research reports and forecasts
  • Quarterly webinars with industry experts
  • Q&A with retail leaders
  • Career advice
  • 10% discount on events
×

Australian pharmaceutical industries

Australian pharmaceutical industries Archives

From the source: Richard Vincent, Australian Pharmaceutical Industries

API keeps its eye firmly on the Priceline shopper – what motivates her purchases and what she is looking for in the stor...

Priceline parent eyes acquisitions

Pharmacy chain looks to strengthen retail portfolio.

Chemist giants go head to head

Pharmacy chains: To float or not to float?

Priceline parent prescribes profit warning

"Suppressed retail trading conditions” impact on pharmacy chain.
Management

Priceline owner books modest growth

Pharmacy firm speeds up omnichannel investments as subdued discretionary spending and rising competitive pressures threa...

API dispenses bumper profit rise

Enlarged network gives Priceline owner a big boost.

Australian Pharmaceutical CEO steps down

Priceline owner's CEO and MD stepping down, company updates guidance.
News

From the source: Stephen Roche, Australian Pharmaceutical Industries

Meet the top man from the parent company of Priceline Pharmacy, Soul Pattinson Chemist and Pharmacist Advice.

Lovisa’s chairman and CFO resign

Boardroom shake-up sees new chairman and CFO appointed.

Priceline operator raises guidance

API forecasts profit increase following strong sales at its Priceline outlets.

API warns of writedown

Pharmacies operator to take $131million hit.

Priceline on the up

Competition in health, beauty, and pharmacy is intense, but confidence appears to be improving as API releases 2013 sale...